Triliance Poly (509046)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹13.42 |
| Market Cap | ₹7 Cr |
| P/E Ratio | 48.56 |
| ROCE | 6.61% |
| ROE | 7.14% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹24.32 — ₹115.34 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹11.14 |
Strengths
- Book value per share of ₹11.14 provides visible asset backing, and P/B of 1.20 means the price is not far above that book value.
- Positive ROE of 7.14% and ROCE of 6.61% suggest the small capital base has at least some reported efficiency.
- Tiny market cap of ₹7 crore and extreme price collapse from ₹115.34 to ₹13.42 reflect deep pessimism, which can occasionally create opportunity if operations revive.
Concerns
- Latest quarter has ₹0 crore sales and ₹0 crore net profit, meaning there is no current earning power.
- P/E of 48.56 is unreliable and unattractive when underlying profit is nil or negligible.
- Piotroski F-Score of 3/9 signals weak fundamental health and possible financial stress.
- Zero dividend, undisclosed promoter holding, and N/A debt/equity leave stewardship and leverage risks hidden.
AI Analysis
This is a tiny ₹7 crore market cap situation, and size alone keeps me honest: small, illiquid names are dangerous when the numbers do not support the story. Triliance Poly has a book value of ₹11.14 per share, so at ₹13.42 the P/B is just 1.20. A Graham buyer would look at that and ask two questions: are the assets really worth book value, and can the business earn a decent return on those assets? Right now the answers are not reassuring. The latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. Sales growth and profit growth are both 0.00%, so there is no visible engine of recovery. The P/E of 48.56 is meaningless when the operating business is earning nothing; it is simply a price multiple on a de minimis number. ROE of 7.14% and ROCE of 6.61% are mediocre, and the Piotroski F-Score of 3 out of 9 is a clear warning that financial health is weak. There is no dividend, debt/equity is not disclosed, and promoter holding is unknown, so I cannot judge whether management is aligned or how leveraged the balance sheet is. The 52-week range, from ₹115.34 down to ₹24.32, shows a stock that has lost enormous value; trading below that low at ₹13.42 tells me the market has little confidence in a near-term revival. Buffett said: 'In the short run, the market is a voting machine, but in the long run it is a weighing machine.' This business currently weighs almost nothing. I would need to see resumption of revenue, a healthier F-Score, and clarity on capital structure before even calling this a designated low-risk asset play. It is a speculative turnaround at best—and in my circle of competence, that is not an investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer